A case study on future proofing the lab with next-generation automation
30 Sept 2024
Lauren Thomas, Executive of Laboratory and Outreach Lab Service, Mercy Southeast describes the installation of the very first Abbott GLP systems Track in the US. The lab’s rapid growth, driven by its outreach program, required technology that could evolve alongside it. Abbott’s next-generation automation systems, particularly the flexible GLP systems Track, provided the adaptability needed to meet changing test and volume demands over time, making them an ideal partner for long-term success.
This video is part of the global #CLINICAL24 2024 conversation.
About the company
Abbott
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 99,000 people.
Related products
Request Quote for All Products
GLP systems Track
AbbottAUTOMATION REINVENTED, FLEXIBILITY REDEFINED. In the United States, the GLP systems Track is FDA cleared and approved. Orderability is pending for certain modules and features.